Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) [Phase 3]
A phase 3b, single-arm study evaluating aflibercept 8 mg every 4 weeks in adults with neovascular age-related macular degeneration or diabet…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD) [Phase 2]
The Phase 2 extension of carbidopa-levodopa for neovascular age-related macular degeneration has completed enrollment. Results were posted o…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Russian Registry of Patients With nAMD
A Russian registry trial for neovascular age-related macular degeneration sponsored by Novartis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) [Phase 3]
A Phase 3 trial of OPT-302 in combination with aflibercept for neovascular age-related macular degeneration was terminated; results have bee…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration [Phase 2]
A Phase 2 study evaluating suprachoroidally administered CLS-AX for neovascular age-related macular degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD) [Phase 3]
Phase 3 trial evaluating OPT-302 in combination with ranibizumab for neovascular age-related macular degeneration has been terminated, with …
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes
This clinical trial update reports early anatomical and functional changes observed with aflibercept 8 mg for neovascular age-related macula…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular Degeneration [Phase 4]
Phase 4 trial evaluating faricimab in high-frequency aflibercept-treated neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS) [Phase 3]
A Phase 3 study evaluating an 8 mg aflibercept (EYLEA) prefilled syringe for diabetic macular edema and neovascular age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients [Phase 1]
A completed Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of IVT MHU650 in macular edema patients. The trial also …
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration [Phase 3]
A Phase 3 clinical trial evaluated associations between the oral and intestinal microbiome and neovascular age-related macular degeneration;…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal
This Portuguese observational study evaluating fluid resolution and effectiveness of brolucizumab for Neovascular Age-Related Macular Degene…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]
Phase 1 clinical trial update evaluating the safety and tolerability of OCU-10-C-110 injections in participants with neovascular age-related…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ONS-5010 in neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]
A 3-month Phase 3 safety study of ONS-5010 in subjects with visual impairment due to retinal disorders has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 clinical effectiveness study of ONS-5010 for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration [Phase 1]
A Phase 1 trial evaluating ARC1905 in combination with Lucentis for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) [Phase 1]
Phase 1 clinical trial update for AIV007 delivered periocularly in patients with macular edema due to Neovascular Age-Related Macular Degene…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab. [Phase 4]
Phase 4 trial update evaluating multimodal imaging biomarkers to predict anatomical outcomes in naive patients with neovascular age-related …
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD) [NA]
This LMU project will evaluate whether an AI second-opinion report used to analyze retinal scans influences doctors' treatment decisions for…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration [Phase 4]
Phase 4 trial evaluating two different 6 mg dosing regimens of brolucizumab for neovascular age-related macular degeneration, reporting on e…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting
A terminated real-world trial evaluating the effectiveness of brolucizumab in pre-treated patients with neovascular age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD) [Phase 1]
A Phase 1 clinical study evaluating the safety and efficacy of SKG0106 for neovascular age-related macular degeneration is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO [Phase 2]
Phase 2 study evaluating the usability of the SB11 prefilled syringe in subjects with wet age-related macular degeneration or macular edema …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration [Phase 1]
A Phase 1 trial evaluating intravitreally administered AIV007 in neovascular age-related macular degeneration has completed. The update note…